Cargando…

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis

AIMS: To clarify the usefulness of left atrial (LA) function and left ventricular (LV) function obtained by two‐dimensional (2D) speckle tracking echocardiography to diagnose concomitant transthyretin amyloid cardiomyopathy (ATTR‐CM) in patients with aortic stenosis (AS). METHODS AND RESULTS: We ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Oike, Fumi, Usuku, Hiroki, Yamamoto, Eiichiro, Marume, Kyohei, Takashio, Seiji, Ishii, Masanobu, Tabata, Noriaki, Fujisue, Koichiro, Yamanaga, Kenshi, Sueta, Daisuke, Hanatani, Shinsuke, Arima, Yuichiro, Araki, Satoshi, Oda, Seitaro, Kawano, Hiroaki, Soejima, Hirofumi, Matsushita, Kenichi, Ueda, Mitsuharu, Fukui, Toshihiro, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065867/
https://www.ncbi.nlm.nih.gov/pubmed/35338611
http://dx.doi.org/10.1002/ehf2.13909
_version_ 1784699683386425344
author Oike, Fumi
Usuku, Hiroki
Yamamoto, Eiichiro
Marume, Kyohei
Takashio, Seiji
Ishii, Masanobu
Tabata, Noriaki
Fujisue, Koichiro
Yamanaga, Kenshi
Sueta, Daisuke
Hanatani, Shinsuke
Arima, Yuichiro
Araki, Satoshi
Oda, Seitaro
Kawano, Hiroaki
Soejima, Hirofumi
Matsushita, Kenichi
Ueda, Mitsuharu
Fukui, Toshihiro
Tsujita, Kenichi
author_facet Oike, Fumi
Usuku, Hiroki
Yamamoto, Eiichiro
Marume, Kyohei
Takashio, Seiji
Ishii, Masanobu
Tabata, Noriaki
Fujisue, Koichiro
Yamanaga, Kenshi
Sueta, Daisuke
Hanatani, Shinsuke
Arima, Yuichiro
Araki, Satoshi
Oda, Seitaro
Kawano, Hiroaki
Soejima, Hirofumi
Matsushita, Kenichi
Ueda, Mitsuharu
Fukui, Toshihiro
Tsujita, Kenichi
author_sort Oike, Fumi
collection PubMed
description AIMS: To clarify the usefulness of left atrial (LA) function and left ventricular (LV) function obtained by two‐dimensional (2D) speckle tracking echocardiography to diagnose concomitant transthyretin amyloid cardiomyopathy (ATTR‐CM) in patients with aortic stenosis (AS). METHODS AND RESULTS: We analysed 72 consecutive patients with moderate to severe AS who underwent (99m)Tc‐pyrophosphate (PYP) scintigraphy at Kumamoto University Hospital from January 2012 to September 2020. We divided these 72 patients into 2 groups based on their (99m)Tc‐PYP scintigraphy positivity or negativity. Among 72 patients, 16 patients (22%) were positive, and 56 patients (78%) were negative for (99m)Tc‐PYP scintigraphy. In clinical baseline characteristics, natural logarithm troponin T was significantly higher in the (99m)Tc‐PYP scintigraphy‐positive than scintigraphy‐negative group (−2.9 ± 0.5 vs. −3.5 ± 0.8 ng/mL, P < 0.05). In conventional echocardiography, the severity of AS was not significantly different between these two groups. In 2D speckle tracking echocardiography, the relative apical longitudinal strain (LS) index (RapLSI) [apical LS/ (basal LS + mid LS)] was significantly higher (1.09 ± 0.49 vs. 0.78 ± 0.23, P < 0.05) and the peak longitudinal strain rate (LSR) in LA was significantly lower in the (99m)Tc‐PYP scintigraphy‐positive than scintigraphy‐negative group (0.36 ± 0.14 vs. 0.55 ± 0.20 s(−1), P < 0.05). Multivariable logistic analysis revealed the peak LSR in LA and RapLSI were significantly associated with (99m)Tc‐PYP scintigraphy positivity. Receiver operating characteristic analysis showed that the area under the curve (AUC) of the peak LSR in LA for (99m)Tc‐PYP scintigraphy positivity was 0.79 and that the best cut‐off value of the peak LSR in LA was 0.47 s(−1) (sensitivity: 78.6% and specificity: 72.3%). The AUC of RapLSI for (99m)Tc‐PYP scintigraphy positivity was 0.69, and the cut‐off value of RapLSI was decided as 1.00 (sensitivity: 43.8% and specificity: 87.5%) according to the previous report. The (99m)Tc‐PYP scintigraphy positivity in patients with RapLSI ≥ 1.0 and the peak LSR in LA ≤ 0.47 s(−1) was 83.3% (5/6), and the (99m)Tc‐PYP scintigraphy negativity in patients with RapLSI < 1.0 and the peak LSR in LA > 0.47 s(−1) was 96.6% (28/29). CONCLUSIONS: Left atrial and LV strain analysis were significantly associated with (99m)Tc‐PYP scintigraphy positivity in ATTR‐CM patients with moderate to severe AS. The combination of the peak LSR in LA and RapLSI might be a useful predictor of the presence of ATTR‐CM in patients with moderate to severe AS.
format Online
Article
Text
id pubmed-9065867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90658672022-05-04 Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis Oike, Fumi Usuku, Hiroki Yamamoto, Eiichiro Marume, Kyohei Takashio, Seiji Ishii, Masanobu Tabata, Noriaki Fujisue, Koichiro Yamanaga, Kenshi Sueta, Daisuke Hanatani, Shinsuke Arima, Yuichiro Araki, Satoshi Oda, Seitaro Kawano, Hiroaki Soejima, Hirofumi Matsushita, Kenichi Ueda, Mitsuharu Fukui, Toshihiro Tsujita, Kenichi ESC Heart Fail Original Articles AIMS: To clarify the usefulness of left atrial (LA) function and left ventricular (LV) function obtained by two‐dimensional (2D) speckle tracking echocardiography to diagnose concomitant transthyretin amyloid cardiomyopathy (ATTR‐CM) in patients with aortic stenosis (AS). METHODS AND RESULTS: We analysed 72 consecutive patients with moderate to severe AS who underwent (99m)Tc‐pyrophosphate (PYP) scintigraphy at Kumamoto University Hospital from January 2012 to September 2020. We divided these 72 patients into 2 groups based on their (99m)Tc‐PYP scintigraphy positivity or negativity. Among 72 patients, 16 patients (22%) were positive, and 56 patients (78%) were negative for (99m)Tc‐PYP scintigraphy. In clinical baseline characteristics, natural logarithm troponin T was significantly higher in the (99m)Tc‐PYP scintigraphy‐positive than scintigraphy‐negative group (−2.9 ± 0.5 vs. −3.5 ± 0.8 ng/mL, P < 0.05). In conventional echocardiography, the severity of AS was not significantly different between these two groups. In 2D speckle tracking echocardiography, the relative apical longitudinal strain (LS) index (RapLSI) [apical LS/ (basal LS + mid LS)] was significantly higher (1.09 ± 0.49 vs. 0.78 ± 0.23, P < 0.05) and the peak longitudinal strain rate (LSR) in LA was significantly lower in the (99m)Tc‐PYP scintigraphy‐positive than scintigraphy‐negative group (0.36 ± 0.14 vs. 0.55 ± 0.20 s(−1), P < 0.05). Multivariable logistic analysis revealed the peak LSR in LA and RapLSI were significantly associated with (99m)Tc‐PYP scintigraphy positivity. Receiver operating characteristic analysis showed that the area under the curve (AUC) of the peak LSR in LA for (99m)Tc‐PYP scintigraphy positivity was 0.79 and that the best cut‐off value of the peak LSR in LA was 0.47 s(−1) (sensitivity: 78.6% and specificity: 72.3%). The AUC of RapLSI for (99m)Tc‐PYP scintigraphy positivity was 0.69, and the cut‐off value of RapLSI was decided as 1.00 (sensitivity: 43.8% and specificity: 87.5%) according to the previous report. The (99m)Tc‐PYP scintigraphy positivity in patients with RapLSI ≥ 1.0 and the peak LSR in LA ≤ 0.47 s(−1) was 83.3% (5/6), and the (99m)Tc‐PYP scintigraphy negativity in patients with RapLSI < 1.0 and the peak LSR in LA > 0.47 s(−1) was 96.6% (28/29). CONCLUSIONS: Left atrial and LV strain analysis were significantly associated with (99m)Tc‐PYP scintigraphy positivity in ATTR‐CM patients with moderate to severe AS. The combination of the peak LSR in LA and RapLSI might be a useful predictor of the presence of ATTR‐CM in patients with moderate to severe AS. John Wiley and Sons Inc. 2022-03-25 /pmc/articles/PMC9065867/ /pubmed/35338611 http://dx.doi.org/10.1002/ehf2.13909 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Oike, Fumi
Usuku, Hiroki
Yamamoto, Eiichiro
Marume, Kyohei
Takashio, Seiji
Ishii, Masanobu
Tabata, Noriaki
Fujisue, Koichiro
Yamanaga, Kenshi
Sueta, Daisuke
Hanatani, Shinsuke
Arima, Yuichiro
Araki, Satoshi
Oda, Seitaro
Kawano, Hiroaki
Soejima, Hirofumi
Matsushita, Kenichi
Ueda, Mitsuharu
Fukui, Toshihiro
Tsujita, Kenichi
Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title_full Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title_fullStr Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title_full_unstemmed Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title_short Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
title_sort utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065867/
https://www.ncbi.nlm.nih.gov/pubmed/35338611
http://dx.doi.org/10.1002/ehf2.13909
work_keys_str_mv AT oikefumi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT usukuhiroki utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT yamamotoeiichiro utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT marumekyohei utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT takashioseiji utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT ishiimasanobu utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT tabatanoriaki utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT fujisuekoichiro utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT yamanagakenshi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT suetadaisuke utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT hanatanishinsuke utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT arimayuichiro utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT arakisatoshi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT odaseitaro utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT kawanohiroaki utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT soejimahirofumi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT matsushitakenichi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT uedamitsuharu utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT fukuitoshihiro utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis
AT tsujitakenichi utilityofleftatrialandventricularstrainfordiagnosisoftransthyretinamyloidcardiomyopathyinaorticstenosis